FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59
Links shared publicly online about this topic.
- 408total visits
FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59
View full resource at drugs.com
Tags: Vaccination, Shingles, STD, Herpes, FDA, Vaccine, Merck & Co.
Most Recently Shared on March 27, 2011 at 9:00 pm By:
FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59 - http://bit.ly/eY0eWo
FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59
drugs.com — “Zostavax (zoster vaccine live) is used for prevention of herpes zoster. Information from Drugs.com includes Zostavax side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 26, 2011 at 7:13 pm By:
Drugs and Devices OW OW Health
FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59: WHITEHOUSE... http://bit.ly/eEOmdE #drug
PharmaLive: FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59
pharmalive.com — “PharmaLive: FDA Expands Indication for Zostavax, Merck's Shingles Vaccine, to Include Adults Ages 50 to 59” View full resource at pharmalive.com
Most Recently Shared on March 25, 2011 at 8:12 pm By:
PharmaLive Pharma and Health News
Daily Advantage - FDA Expands Age Indication for Shingles Vaccine - http://tinyurl.com/4n9cuqk
Advertisement
